Breaking News Instant updates and real-time market news.

WDAY

Workday

$130.36

-2.62 (-1.97%)

, DIS

Disney

$115.43

(0.00%)

09:39
11/06/18
11/06
09:39
11/06/18
09:39

Workday likely closed Disney deal at end of Q3, says Cleveland Research

Cleveland Research said research suggests Workday (WDAY) likely closed the Disney (DIS) deal at the end of Q3. The firm's analyst believes large deal likely finished ahead of Q3 expectations, with prior work indicating Comcast (CMSA) and H&R Block (HRB) also were won in the quarter.

WDAY

Workday

$130.36

-2.62 (-1.97%)

DIS

Disney

$115.43

(0.00%)

  • 08

    Nov

  • 13

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

  • 04

    Dec

WDAY Workday
$130.36

-2.62 (-1.97%)

10/17/18
10/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Infosys (INFY) upgraded to Market Perform from Underperform at William Blair WITH analyst Maggie Nolan citing Q2 results. 2. American Airlines (AAL), Delta Air Lines (DAL), and United Continental (UAL) upgraded to Buy from Hold at Deutsche Bank. 3. Akorn (AKRX) upgraded to Overweight from Neutral at Piper Jaffray with analyst David Amsellem saying based on trends associated with a number of its notable products, as well as his recent conversation with management, he believes a picture of sustainable EBITDA is emerging at Akorn that is better than what he had previously envisioned. 4. Workday (WDAY) upgraded to Outperform from Market Perform at Bernstein with analyst Mark Moerdler saying he determined that even if the ERP market moves reasonably slowly to the Cloud, it is large enough and the fact there are only a few vendors with a competitive SaaS solution should allow Workday to continue to gain share. 5. Domino's Pizza (DPZ) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson saying the pullback in the stock price is overdone and expects accelerated cost savings and solid comps to yield higher earnings, raising his FY20 EPS view to $12.01 from $11.72. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/17/18
BERN
10/17/18
UPGRADE
BERN
Outperform
Workday upgraded to Outperform on long-term growth at Bernstein
As previously reported, Bernstein analyst Mark Moerdler upgraded Workday (WDAY) to Outperform from Market Perform. After looking into the ERP market in his recent multi-part ERP Primer series, the analyst has determined that even if the ERP market moves reasonably slowly to the Cloud, it is large enough and the fact there are only a few vendors with a competitive SaaS solution should allow Workday to continue to gain share. In fact, Moerdler believes that the market is large enough that even if Workday does not take customers from Oracle (ORCL) or SAP (SAP), it can still grow its subscription revenue with a 24%-36% 5-year CAGR through 2022.
10/17/18
BERN
10/17/18
UPGRADE
BERN
Outperform
Workday upgraded to Outperform from Market Perform at Bernstein
10/03/18
NEED
10/03/18
NO CHANGE
Target $170
NEED
Buy
Workday customer conference highlighted 'continued strong demand', says Needham
Needham analyst Scott Berg kept his Buy rating and $170 price target on Workday after attending the company's annual customer conference yesterday. The analyst says the discussions with Workday's partners and customers indicate "continued strong demand" with its Financials platform which may "further accelerate" from the current y/y levels. Berg believes that its ongoing growth could yield a 30% subscription revenue gains over the next two years, even though he saw the company's new product announcements as "underwhelming".
DIS Disney
$115.43

(0.00%)

10/19/18
10/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Overweight from Equal Weight at Barclays with analyst Kannan Venkateshwar saying the stock is likely to become a "core holding" again. 2. Dentsply Sirona (XRAY) double upgraded to Buy from Sell at Goldman Sachs with analyst Nathan Rich saying he now believes consensus estimates are achievable and that Dentsply's valuation is attractive relative to Medtech peers. 3. PayPal (PYPL) upgraded to Buy from Neutral at BTIG with analyst Mark Palmer saying the company's Venmo monetization progress was the deciding factor in his rating change. 4. Roku (ROKU) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney saying the company's valuation has become more attractive following a 25% pullback in its stock price but believes Roku offers the "best opportunity for upwards estimates revisions." 5. O'Reilly Automotive (ORLY) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Horvers saying he sees "strong" fundamentals with "structurally positive industry factors." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/19/18
LEHM
10/19/18
UPGRADE
Target $130
LEHM
Overweight
Barclays sees Disney becoming 'core holding' again, upgrades to Overweight
Barclays analyst Kannan Venkateshwar upgraded Disney to Overweight from Equal Weight and raised his price target for the shares to $130 from $105. The shares closed yesterday down 91c to $116.18. The stock is likely to become a "core holding" again, Venkateshwar tells investors in a research note partially titled "The Force Awakens." While almost everything about Disney's over-the-top story is conjecture and success is not a given, the company has the "key mix of assets to be successful and the opportunity from this pivot could be substantial," contends the analyst. He believes Disney's investor day could prove to be a catalyst to frame the scale of the OTT opportunity and help the company build a credible terminal value "story"' around the stock. And the analyst thinks current media multiples are more about terminal value optionality than near-term core trends. "In this respect, there are a few other names with a credible terminal value story other than Disney," writes Venkateshwar.
10/19/18
LEHM
10/19/18
UPGRADE
Target $130
LEHM
Overweight
Disney upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Kannan Venkateshwar upgraded Disney to Overweight from Equal Weight and raised his price target for the shares to $130 from $105.
10/15/18
MSCO
10/15/18
NO CHANGE
Target $135
MSCO
Overweight
Disney shares appear 'compelling' at current levels, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne believes Disney (DIS) shares appear "compelling" at a current valuation of under 13x "core" FY20 pro forma EPS given the company's opportunity to maximize the potential of the acquired Fox (FOXA) assets and scale a direct-to-consumer business. He attributes investor reluctance to own Disney shares to uncertainty about its ability to simultaneously execute on a large acquisition, launch a global direct-to-consumer business and grow, but Swinburne sees this "complexity discount" as an opportunity, he tells investors. He maintains an Overweight rating on Disney shares with a $135 price target.

TODAY'S FREE FLY STORIES

AMAT

Applied Materials

$35.03

1.44 (4.29%)

, LRCX

Lam Research

$146.41

3.62 (2.54%)

07:31
11/16/18
11/16
07:31
11/16/18
07:31
Recommendations
Applied Materials, Lam Research analyst commentary  »

Applied Materials price…

AMAT

Applied Materials

$35.03

1.44 (4.29%)

LRCX

Lam Research

$146.41

3.62 (2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

VBLT

VBL Therapeutics

$1.14

-0.04 (-3.39%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Hot Stocks
VBL Therapeutics reports results from GLOBE study at SNO »

VBL Therapeutics reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

, QURE

uniQure

$31.00

8.21 (36.02%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Upgrade
Spark Therapeutics, uniQure rating change  »

Spark Therapeutics…

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

QURE

uniQure

$31.00

8.21 (36.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$55.49

1.09 (2.00%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Recommendations
Anadarko analyst commentary  »

Anadarko strategic update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
Nvidia analyst commentary  »

Nvidia likely to remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

AXP

American Express

$109.52

1.75 (1.62%)

, COF

Capital One

$89.21

0.29 (0.33%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
American Express, Capital One analyst commentary  »

American Express new top…

AXP

American Express

$109.52

1.75 (1.62%)

COF

Capital One

$89.21

0.29 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BCRX

BioCryst

$7.31

0.31 (4.43%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Hot Stocks
BioCryst presents BCX7353 data at ACAAI meeting »

BioCryst presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

UBSH

Union Bankshares

$34.26

0.455 (1.35%)

07:25
11/16/18
11/16
07:25
11/16/18
07:25
Recommendations
Union Bankshares analyst commentary  »

Union Bankshares deserves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:24
11/16/18
11/16
07:24
11/16/18
07:24
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

TPR

Tapestry

$40.99

-0.11 (-0.27%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Tapestry analyst commentary  »

Tapestry price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

IFF

International Flavors

$142.28

1.01 (0.71%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Initiation
International Flavors initiated  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOG

GasLog

$20.02

0.17 (0.86%)

, GLOP

GasLog Partners

$24.01

0.16 (0.67%)

07:22
11/16/18
11/16
07:22
11/16/18
07:22
Hot Stocks
GasLog, GasLog Partners to modify IDR »

GasLog (GLOG) and GasLog…

GLOG

GasLog

$20.02

0.17 (0.86%)

GLOP

GasLog Partners

$24.01

0.16 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$47.22

-0.77 (-1.60%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Downgrade
Michael Kors rating change  »

Michael Kors downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

GAB

Gabelli Eqty Trust

$6.03

0.02 (0.33%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Hot Stocks
Gabelli backs 10% distribution policy, raises Q4 distribution to 19c per share »

The board of The Gabelli…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
FX Update: The dollar has traded mixed »

FX Update: The dollar has…

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
Canada manufacturing preview »

Canada manufacturing…

AMAT

Applied Materials

$35.03

1.44 (4.29%)

07:19
11/16/18
11/16
07:19
11/16/18
07:19
Recommendations
Applied Materials analyst commentary  »

Citi adds Applied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Blueprint Medicines analyst commentary  »

Blueprint Medicines data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

CUB

Cubic

$65.71

1.78 (2.78%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Cubic analyst commentary  »

Cubic well positioned for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.59

1.09 (1.72%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Periodicals
Citi says clients are adjusting supply chains due to trade war, CNBC reports »

Citi said their corporate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

SIGI

Selective Insurance

$64.11

1.81 (2.91%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Initiation
Selective Insurance initiated  »

Selective Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AGIO

Agios Pharmaceuticals

$67.26

3.54 (5.56%)

07:16
11/16/18
11/16
07:16
11/16/18
07:16
Hot Stocks
Agios Pharmaceuticals presents data from AG-881 study at SNO »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.